Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes

NCT00437112 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Human Insulin Inhalation Powder
DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company

Collaborators

[object Object]